Haizeng Zhang Selected Research

norswertianolin

1/2021

Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haizeng Zhang Research Topics

Disease

12	Neoplasms (Cancer) 11/2021 - 11/2002
6	Rectal Neoplasms (Rectal Cancer) 04/2021 - 11/2002
2	Hypoxia (Hypoxemia) 01/2018 - 11/2010
1	Non-alcoholic Fatty Liver Disease 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Inflammation (Inflammations) 12/2022
1	Insulin Resistance 12/2022
1	Atherosclerosis 10/2022
1	Atherosclerotic Plaque (Atheroma) 10/2022
1	Glucose Intolerance 08/2022
1	Melanoma (Melanoma, Malignant) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Reperfusion Injury 01/2021
1	Ischemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Extranodal Extension 10/2020
1	Vascular Remodeling 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2018
1	Neuroinflammatory Diseases 01/2018
1	Neoplasm Metastasis (Metastasis) 06/2017
1	Pathologic Complete Response 06/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Dysbiosis 08/2013
1	Stomach Neoplasms (Stomach Cancer) 07/2011
1	Carcinoma (Carcinomatosis) 11/2002
1	Hemorrhage 11/2002

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2018
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2022 - 01/2021
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2018
2	CystathionineIBA 12/2022 - 01/2021
2	EnzymesIBA 12/2022 - 01/2015
2	LyasesIBA 12/2022 - 01/2021
2	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 10/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 12/2018
2	apelin-13 peptideIBA 01/2020 - 01/2018
2	KynurenineIBA 12/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 11/2010
1	LipidsIBA 12/2022
1	Pharmaceutical PreparationsIBA 12/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	Oleic Acid (Oleate)IBA 12/2022
1	CollagenIBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	GasotransmittersIBA 10/2022
1	Small Interfering RNA (siRNA)IBA 08/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	norswertianolinIBA 01/2021
1	PerforinIBA 01/2021
1	LigandsIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 10/2018
1	4-phenylbutyric acid (Buphenyl)FDA Link 10/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2018
1	ResveratrolIBA 01/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2018
1	ImmunosorbentsIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2014
1	Estrogen ReceptorsIBA 04/2014
1	Butyrates (Butyrate)IBA 08/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2011
1	Vascular Endothelial Growth FactorsIBA 07/2011
1	Vascular Endothelial Growth Factor DIBA 07/2011
1	Hypoxia-Inducible Factor 1IBA 11/2010
1	Peptide Hydrolases (Proteases)FDA Link 11/2010

Therapy/Procedure

5	Neoadjuvant Therapy 04/2021 - 06/2015
2	Immunotherapy 11/2021 - 01/2021
2	Therapeutics 12/2018 - 06/2015
1	Colectomy 11/2002
1	Radiotherapy 11/2002
1	Proctectomy 11/2002
1	Drug Therapy (Chemotherapy) 11/2002